CHIARAMONTE, ELOISA

CHIARAMONTE, ELOISA  

Universita' degli Studi di MILANO  

Risultati 1 - 15 di 15 (tempo di esecuzione: 0.007 secondi).
Titolo Data di pubblicazione Autore(i) Tipo File Abstract
ALTERAZIONI ISTOPATOLOGICHE INDOTTE DA CELLULE UMANE LAM/TSC IN TOPI NUDI: UN MODELLO DI LINFANGIOLEIOMIOMATOSI. REVERSIONE DEL DANNO CON ANTICORPO ANTI-EGFR 27-feb-2012 E. Chiaramonte Doctoral Thesis -
Anti-EGFR antibody reduces lung nodules by inhibition of EGFR-pathway in a model of lymphangioleiomyomatosis 1-gen-2015 E. LesmaE. ChiaramonteS. AnconaE. OrpianesiA.M. Di GiulioA. Gorio Article (author) -
Characterization of LAM/TSC cells isolated from patient chylous 13-apr-2010 E. LesmaS. AnconaV. GrandeS.M. SirchiaE. ChiaramonteS. BosariA.M. Di GiulioA. Gorio Conference Object -
Development of a LAM model by using human TSC2 deficient smooth muscle cells derived from a renal angiomylipoma 12-apr-2010 E. LesmaE. ChiaramonteV. GrandeS. AnconaA.M. Di GiulioA. Gorio Conference Object -
Development of a lymphangioleiomyomatosis model by endonasal administration of human TSC2-/- smooth muscle cells in mice 1-set-2012 E. LesmaE. ChiaramonteS. AnconaE. OrpianesiA.M. Di GiulioA. Gorio + Article (author) -
Differential modulation of matrix metalloproteinases-2 and-7 in LAM/TSC cells 24-nov-2021 Ancona S.Orpianesi E.Bernardelli C.Chiaramonte E.Chiaramonte R.Terraneo S.Di Marco F.Lesma E. Article (author) -
An epigenetic event may underlies the TSC features in TSC2 ASM cells 1-set-2009 E. LesmaS. AnconaS.M. SirchiaV. GrandeE. ChiaramonteS. BosariA.M. Di GiulioA. Gorio Conference Object -
Human smooth muscle TSC2-/- cells cause lymphangiogenesis-like lung destruction in nude mice. Pharmacological repair 1-gen-2009 E. LesmaE. ChiaramonteS. AnconaV. GrandeR. AdamiA.M. Di GiulioA. Gorio Conference Object -
LAM/TSC cell migration to uterus in an experimental model of lymphangioleiomyomatosis. Regulation by anti-epidermal growth factor receptor antibody and rapamycin 1-gen-2014 E. LesmaE. ChiaramonteS. AnconaA.M. Di GiulioA. Gorio Article (author) -
Un modello di linfangioleiomiomatosi con la somministrazione di cellule muscolari lisce umane TSC2-/- 22-ott-2010 E. LesmaE. ChiaramonteV. GrandeS. AnconaF. La BriolaM.P. CaneviniCORONA, MASSIMILIANOF. GhelmaA.M. Di GiulioA. Gorio Conference Object -
A mouse LAM model by endonasal administration of human TSC2 deficient smooth muscle cells 1-mag-2010 E. LesmaE. ChiaramonteS. AnconaV. GrandeA.M. Di GiulioA. Gorio Article (author) -
Pathogenesis and pharmacological evaluation of human TSC2 smooth muscle cells. Possible treatment options for TSC and lymphangioleiomyomatosis 1-gen-2009 E. LesmaV. GrandeS. AnconaE. ChiaramonteS. M. SirchiaA. M. Di GiulioA. Gorio Conference Object -
Promoter methylation of TSC2 gene is important for pathogenesis of TSC and LAM lesions 1-gen-2009 S. AnconaE. LesmaS.M. SirchiaV. GrandeE. ChiaramonteA.M. Di GiulioA. Gorio Conference Object -
Role of HMG-CoA reductase inhibitors in controlling TSC2-/- ASM cell growth and proliferation 1-gen-2009 V. GrandeE. LesmaS. AnconaE. ChiaramonteA.M. Di GiulioA. Gorio Conference Object -
TSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival 1-mar-2014 E. LesmaS. AnconaS.M. SirchiaE. OrpianesiV. GrandeP. ColapietroE. ChiaramonteA.M. Di GiulioA. Gorio Article (author) -